Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Caplin Point Laboratories Limited (NSE: CAPLIPOINT), ISIN INE475E01026 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
CAPLIPOINT last traded at ₹2791.30 (+0.43%), with a 52-week range of ₹1502.45 to ₹2874.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 70.57%, FIIs 5.75%, DIIs 2.49%, mutual funds 2.03%.
EquiSense Score (ECS): 80/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.